JPMorgan Chase & Co. Sells 119,253 Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG)

JPMorgan Chase & Co. lowered its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 72.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 44,365 shares of the company’s stock after selling 119,253 shares during the quarter. JPMorgan Chase & Co.’s holdings in BrightSpring Health Services were worth $756,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new stake in BrightSpring Health Services during the 4th quarter valued at approximately $18,257,000. Vanguard Group Inc. raised its stake in BrightSpring Health Services by 5.3% during the 4th quarter. Vanguard Group Inc. now owns 5,325,093 shares of the company’s stock valued at $90,686,000 after purchasing an additional 268,132 shares during the period. Barclays PLC raised its stake in BrightSpring Health Services by 22.2% during the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock valued at $5,780,000 after purchasing an additional 71,633 shares during the period. Quantbot Technologies LP raised its stake in BrightSpring Health Services by 120.0% during the 4th quarter. Quantbot Technologies LP now owns 82,369 shares of the company’s stock valued at $1,403,000 after purchasing an additional 44,937 shares during the period. Finally, Virtu Financial LLC bought a new stake in BrightSpring Health Services during the 3rd quarter valued at approximately $522,000.

BrightSpring Health Services Trading Up 2.3 %

Shares of BTSG opened at $17.31 on Tuesday. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. BrightSpring Health Services, Inc. has a fifty-two week low of $10.15 and a fifty-two week high of $24.82. The stock has a market capitalization of $3.03 billion, a PE ratio of -66.58 and a beta of 2.02. The company’s fifty day moving average is $17.72 and its 200 day moving average is $18.44.

Analyst Ratings Changes

Separately, UBS Group upped their price objective on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $21.67.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.